Benchmark Capital Advisors’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $39K | Sell |
3,400
-546
| -14% | -$6.26K | 0.04% | 109 |
|
|
2018
Q3 | $79K | Hold |
3,946
| – | – | 0.06% | 128 |
|
|
2018
Q2 | $99K | Sell |
3,946
-640
| -14% | -$16.1K | 0.07% | 125 |
|
|
2018
Q1 | $118K | Sell |
4,586
-210
| -4% | -$5.4K | 0.09% | 124 |
|
|
2017
Q4 | $122K | Sell |
4,796
-2,780
| -37% | -$70.7K | 0.1% | 128 |
|
|
2017
Q3 | $213K | Sell |
7,576
-458
| -6% | -$12.9K | 0.17% | 115 |
|
|
2017
Q2 | $241K | Sell |
8,034
-60
| -0.7% | -$1.8K | 0.19% | 105 |
|
|
2017
Q1 | $241K | Sell |
8,094
-1,414
| -15% | -$42.1K | 0.19% | 99 |
|
|
2016
Q4 | $329K | Sell |
9,508
-9,840
| -51% | -$340K | 0.27% | 78 |
|
|
2016
Q3 | $1.28M | Buy |
19,348
+1,140
| +6% | +$75.4K | 0.97% | 36 |
|
|
2016
Q2 | $1.03M | Buy |
18,208
+1,500
| +9% | +$85K | 0.84% | 40 |
|
|
2016
Q1 | $974K | Sell |
16,708
-1,040
| -6% | -$60.6K | 0.85% | 40 |
|
|
2015
Q4 | $1.04M | Sell |
17,748
-240
| -1% | -$14.1K | 0.88% | 39 |
|
|
2015
Q3 | $1.03M | Sell |
17,988
-500
| -3% | -$28.6K | 0.84% | 40 |
|
|
2015
Q2 | $1.67M | Hold |
18,488
| – | – | 1.17% | 30 |
|
|
2015
Q1 | $1.78M | Buy |
18,488
+4,017
| +28% | +$387K | 1.17% | 27 |
|
|
2014
Q4 | $1.27M | Buy |
14,471
+260
| +2% | +$22.8K | 0.85% | 39 |
|
|
2014
Q3 | $1.3M | Buy |
14,211
+2,820
| +25% | +$258K | 0.9% | 37 |
|
|
2014
Q2 | $1.31M | Hold |
11,391
| – | – | 0.82% | 44 |
|
|
2014
Q1 | $1.38M | Hold |
11,391
| – | – | 0.96% | 36 |
|
|
2013
Q4 | $1.43M | Hold |
11,391
| – | – | 0.99% | 35 |
|
|
2013
Q3 | $1.24M | Buy |
11,391
+1,071
| +10% | +$116K | 0.89% | 38 |
|
|
2013
Q2 | $869K | Buy |
+10,320
| New | +$869K | 0.67% | 48 |
|